- Home
- SGHT vs BETR Comparison
SGHT vs BETR Comparison
Compare SGHT & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- BETR
- Stock Information
- Founded
- SGHT 2011
- BETR 2014
- Country
- SGHT United States
- BETR United States
- Employees
- SGHT N/A
- BETR N/A
- Industry
- SGHT Medical Specialities
- BETR Finance: Consumer Services
- Sector
- SGHT Health Care
- BETR Finance
- Exchange
- SGHT Nasdaq
- BETR Nasdaq
- Market Cap
- SGHT 179.7M
- BETR 203.4M
- IPO Year
- SGHT 2021
- BETR N/A
- Fundamental
- Price
- SGHT $3.69
- BETR $23.97
- Analyst Decision
- SGHT Buy
- BETR
- Analyst Count
- SGHT 8
- BETR 0
- Target Price
- SGHT $4.29
- BETR N/A
- AVG Volume (30 Days)
- SGHT 125.0K
- BETR 75.9K
- Earning Date
- SGHT 11-06-2025
- BETR 08-13-2025
- Dividend Yield
- SGHT N/A
- BETR N/A
- EPS Growth
- SGHT N/A
- BETR N/A
- EPS
- SGHT N/A
- BETR N/A
- Revenue
- SGHT $76,303,000.00
- BETR $130,672,000.00
- Revenue This Year
- SGHT N/A
- BETR $55.38
- Revenue Next Year
- SGHT $11.32
- BETR $71.18
- P/E Ratio
- SGHT N/A
- BETR N/A
- Revenue Growth
- SGHT N/A
- BETR 69.42
- 52 Week Low
- SGHT $2.03
- BETR $7.71
- 52 Week High
- SGHT $7.03
- BETR $23.98
- Technical
- Relative Strength Index (RSI)
- SGHT 39.74
- BETR 75.97
- Support Level
- SGHT $4.09
- BETR $21.64
- Resistance Level
- SGHT $4.25
- BETR $23.27
- Average True Range (ATR)
- SGHT 0.16
- BETR 1.49
- MACD
- SGHT -0.07
- BETR 0.41
- Stochastic Oscillator
- SGHT 9.16
- BETR 99.87
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a digital-first homeownership company whose services include mortgage, real estate, title, and homeowners insurance. The company has combined technology innovation and fresh thinking with a deep customer focus with the goal of revolutionizing the homeownership industry.